Latest Tariffs News

Delegat Group has raised its full-year Operating Net Profit after Tax forecast to $60-62 million, up from $50-55 million, driven by stronger global sales, lower US tariffs, and favourable FX.

Kingfish Limited's May update reveals a robust 5.5% portfolio return, driven by standout performances from Fisher & Paykel Healthcare and Infratil amid mixed sector headwinds.

Steel & Tube has secured a one-year extension on its ANZ banking facilities, underpinning financial stability as trading conditions soften due to geopolitical tensions and sector-specific pressures.

Templeton Emerging Markets Investment Trust (TEMIT) posted a robust 41.3% net asset value total return for FY2026, outpacing its benchmark and narrowing its share price discount, while maintaining dividends and expanding share buybacks.

8I Holdings Limited boosted its investment gains sixfold to S$1.28 million in FY2026, driven by U.S. tech equities, yet geopolitical turmoil and currency swings led to a reduced net loss of S$0.36 million.

Burgundy Diamond Mines announces a court-approved extension and financing for Arctic Canadian Diamond Company Ltd, alongside appointing Brent Mierau as CFO to steer through ongoing market challenges.

AoFrio Limited is offering existing shareholders a 1-for-7 rights issue at NZ$0.07 per share following a NZ$4.56 million placement, aiming to raise nearly NZ$5 million to fund growth ambitions.

Ainsworth Game Technology posted a 10% revenue increase in FY25 to $291 million, driven by strong Asia Pacific growth, while North American challenges weigh on H1 2026 outlook.

KMD Brands delivered steady sales growth and margin improvement in Q3 FY26, driven by Kathmandu and Rip Curl, while launching a business review to explore options for accelerating shareholder value.

Aroa Biosurgery posted a breakout FY26, beating revenue and EBITDA guidance with a 54% surge in Myriad sales. The company plans significant investments in FY27 to accelerate growth and capitalise on new market opportunities.

Fisher & Paykel Healthcare posted a 14% revenue increase to NZ$2.31 billion and a 24% rise in net profit to NZ$468.5 million for FY2026, driven by strong hospital product sales and ongoing innovation.

BLIS Technologies posted a 16% revenue increase to $14.7 million in FY26, resolving a key intellectual property dispute and expanding strategic partnerships, including an extended Probi AB agreement that now covers pet nutrition.